Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan

YUKI KOBARI; JUNPEI IIZUKA; HANAE KONDO; MAKIKO ICHIOKA; SHUN WATANABE; KAZUTAKA NAKAMURA; YUKI NEMOTO; TOSHIHIDE HORIUCHI; SHINSUKE MIZOGUCHI; KAZUHIKO YOSHIDA; HIROAKI SHIMMURA; YASUNOBU HASHIMOTO; TSUNENORI KONDO; HIROSHI KOBAYASHI; TOSHIO TAKAGI

doi:10.21873/anticanres.17898

Research ArticleClinical Studies

Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan

YUKI KOBARI, JUNPEI IIZUKA, HANAE KONDO, MAKIKO ICHIOKA, SHUN WATANABE, KAZUTAKA NAKAMURA, YUKI NEMOTO, TOSHIHIDE HORIUCHI, SHINSUKE MIZOGUCHI, KAZUHIKO YOSHIDA, HIROAKI SHIMMURA, YASUNOBU HASHIMOTO, TSUNENORI KONDO, HIROSHI KOBAYASHI and TOSHIO TAKAGI

Anticancer Research December 2025, 45 (12) 5645-5654; DOI: https://doi.org/10.21873/anticanres.17898

YUKI KOBARI

1Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: yuukikobari17{at}gmail.com

JUNPEI IIZUKA

1Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HANAE KONDO

2Department of Urology, Saiseikai Kawaguchi General Hospital, Kawaguchi, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MAKIKO ICHIOKA

1Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SHUN WATANABE

1Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KAZUTAKA NAKAMURA

1Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YUKI NEMOTO

3Department of Urology, Joban Hospital, Fukushima, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TOSHIHIDE HORIUCHI

4Department of Urology, Tokyo Women’s Medical University, Adachi Medical Center, Adachi, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SHINSUKE MIZOGUCHI

5Department of Urology, Saiseikai Kazo Hospital, Kazo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KAZUHIKO YOSHIDA

1Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HIROAKI SHIMMURA

3Department of Urology, Joban Hospital, Fukushima, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YASUNOBU HASHIMOTO

2Department of Urology, Saiseikai Kawaguchi General Hospital, Kawaguchi, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TSUNENORI KONDO

4Department of Urology, Tokyo Women’s Medical University, Adachi Medical Center, Adachi, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HIROSHI KOBAYASHI

5Department of Urology, Saiseikai Kazo Hospital, Kazo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TOSHIO TAKAGI

1Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Information

vol. 45 no. 12 5645-5654

DOI

https://doi.org/10.21873/anticanres.17898

PMID

41318114

Published By

International Institute of Anticancer Research

Print ISSN

0250-7005

Online ISSN

1791-7530

History

Received August 11, 2025
Revision received September 6, 2025
Accepted September 16, 2025
Published online November 29, 2025.

Author Information

YUKI KOBARI¹ ⇑,
JUNPEI IIZUKA¹,
HANAE KONDO²,
MAKIKO ICHIOKA¹,
SHUN WATANABE¹,
KAZUTAKA NAKAMURA¹,
YUKI NEMOTO³,
TOSHIHIDE HORIUCHI⁴,
SHINSUKE MIZOGUCHI⁵,
KAZUHIKO YOSHIDA¹,
HIROAKI SHIMMURA³,
YASUNOBU HASHIMOTO²,
TSUNENORI KONDO⁴,
HIROSHI KOBAYASHI⁵ and
TOSHIO TAKAGI¹

¹Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;
²Department of Urology, Saiseikai Kawaguchi General Hospital, Kawaguchi, Japan;
³Department of Urology, Joban Hospital, Fukushima, Japan;
⁴Department of Urology, Tokyo Women’s Medical University, Adachi Medical Center, Adachi, Japan;
⁵Department of Urology, Saiseikai Kazo Hospital, Kazo, Japan

Yuki Kobari, MD, Ph.D., Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan. Tel: +81 333538111, Fax: +81 333560293, e-mail: yuukikobari17{at}gmail.com

View Full Text

Statistics from Altmetric.com

Cited By...

Citations
Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext

In this issue

Anticancer Research

Vol. 45, Issue 12

December 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Ed Board (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 6 + 12 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan

Anticancer Research Dec 2025, 45 (12) 5645-5654; DOI: 10.21873/anticanres.17898

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan

Anticancer Research Dec 2025, 45 (12) 5645-5654; DOI: 10.21873/anticanres.17898

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

No citing articles found.

Google Scholar

Keywords

enfortumab vedotin
Chronic kidney disease
Urothelial carcinoma
renal function

Main menu

User menu

Search

Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan

Article Information

Author Information

Statistics from Altmetric.com

Cited By...

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords